424.5 EUR
2.3
0.54%
Last update Dec 16, 7:37 PM CET
Market closed
Day range
419
425
Previous close
422.20001
Open
422.5
Access this stock data via API
Subscribe
United Therapeutics Corporation
424.50
2.30
0.54%

Financials

Income statement

Fundamentals currency is USD
Fiscal date 2024 2023 2022 2021
Total reported revenue 2.5B 2.3B 1.9B 1.7B
Cost of revenue 263.8M 257.5M 151.6M 122.5M
Gross profit 2.2B 2.1B 1.8B 1.6B
Operating expense
Research & development 409.7M 408M 322.9M 540.1M
Selling general and admin 543.9M 477.1M 482.1M 467M
Other operating expenses
Operating income 1.2B 1.2B 979.7M 555.9M
Non operating interest income
Income 169.6M 162.7M 45.2M 16.7M
Expense 36.5M 59.3M 32.4M 18.6M
Other income expense -55.6M -14M -41.9M 39.9M
Pretax income 1.3B 1.3B 950.6M 593.9M
Tax provision 292.9M 289.5M 223.3M 118.1M
Net income 1.0B 984.8M 727.3M 475.8M
Basic EPS 26.4 21.0 16.0 10.6
Diluted EPS 24.6 19.8 15 10.1
Basic average shares 38.5M 49.1M 47.4M 46.7M
Diluted average shares 38.5M 49.1M 47.4M 46.7M
EBITDA 1.5B 1.4B 1.0B 664.7M
Net income from continuing op. 1.0B 984.8M 727.3M 475.8M
Minority interests
Preferred stock dividends
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Market closed

Exchange is currently closed
Main market opens in 5 hours 35 minutes

02:24
00:00
08:00
20:00
23:59

Trading Hours (Monday - Friday):

Main market
08:00 - 20:00
All times are displayed in the Europe/Berlin timezone (CET, UTC+01:00).